Current controversies in the biology and management of ovarian tumors of low malignant potential

References

• Taylor HC. Malignant and semimalignant tumors of the ovary. Surg Gynecol Obstet 1929;48:204–230
   Google Scholar
• International Federation of Gynecology and Obstetrics. Classification and staging of malignant tumors in the female pelvis. Acta Obstet Gynecol Scand 1971;50:1–7
   Google Scholar
• Buttin BM, Herzog TJ, Powell MA, Rader JS, Mutch DG. Epithelial ovarian tumors of low malignant potential: the role of microinvasion. Obstet Gynecol 2002;99:11–17
   Google Scholar
• Deavers MT, Gershenson DM, Tortolero-Luna G, Malpica A, Lu K, Silva EG. Micropapillary and cribriform patterns in ovarian serous tumors of low malignant potential. Am J Surg Path 2002;26:1129–1141
   Google Scholar
• Gershenson DM, Silva EG, Levy L, Burke TW, Wolf JK, Tornos C. Ovarian serous borderline tumors with invasive peritoneal implants. Cancer 1998;82:1096–1103
   PubMed Web of Science ®Google Scholar
• Seidman JD, Kurman RJ. Subclassification of serous borderline tumors of the ovary into benign malignant types: a clinicopathologic study of 65 advanced stage cases. Am J Surg Path 1996;20:1331–1345
   PubMed Web of Science ®Google Scholar
• Seidman JD, Kurman RJ. Ovarian serous borderline tumors: a critical review fo the literature with emphasis on prognostic indicators. Hum Pathol 2000; 31:539–557
   PubMed Web of Science ®Google Scholar
• Longacre TA, McKenney JK, Tazelaar HD, Kempson RL, Hendrickson MR. Ovarian serous tumors of low malig-nant potential (borderline tumors): outcome-based study of 276 patients with long term ( >5-year) follow-up. Am J Surg Path 2005;29: 707–723
   Google Scholar
• Crispens MA, Bodurka D, Deavers MT, Lu K, Silva EG, Gershenson DM. Response and survival in patients with progressive or recurrent serous ovarian tumors of low malignant potential. Obstet Gynecol 2002;99:3–10
   Google Scholar
• Kennedy AW, Hart WR. Ovarian papillary serous tumors of low malignant potential (serous borderline tumors): a long term follow-up study, including patients with microinvasion, lymph node metastasis, and transforma-tion to invasive serous carcinoma. Cancer 1996;78:278–286
   PubMed Web of Science ®Google Scholar
• Morice P, Camatte S, Rey A, Atallah D, Lhomme C, Pautier P, et al. Prognostic factors for patients with advanced stage serous borderline tumours of the ovary. Annals Oncol 2003;14:592–598
   PubMed Web of Science ®Google Scholar
• Zanetta G, Rota S, Chiari S, Bonazzi C, Bratina G, Mangioni C. Behaviour of borderline tumors with particular interest to persistence, recurrence, and progres-sion to invasive carcinoma: a prospective study. J Clin Oncol 2001;19:2658–2664
   PubMed Web of Science ®Google Scholar
• Silva EG, Tomos C, Zhuang Z, Merino MJ, Gershenson DM. Tumor recurrence in stage I ovarian serous neoplasms of low malignant potential. Int J Gynecol Pathol 1998;17:1–6
   Google Scholar
• Trope C, Kaem J. Management of borderline tumors of the ovary: state of the art. Semin Oncol 1998; 25:372–380
   Google Scholar
• Winter III WE, Kucera PR, Rodgers W, McBroom JW, Olsen C, Maxwell GL. Surgical staging in patients with ovarian tumors of low malignant potential. Obstet Gynecol 2002;100:671–676
   Google Scholar
• Jimenez AM, Miralles RM, Sanchez AE, Martinez LG, Mundo EC, Llado LB. Ovarian tumors of low malignant potential (borderline). Eur J Gynaecol Oncol 1994; 15:300–304
   Google Scholar
• Hinke V, Martin MC. Ovarian carcinoma of low malignant potential treated at the Jewish General Hospital, Montreal, between 1973 and 1997. Can J Surg 1999;42:253
   Google Scholar
• Darai E, Teboul J, Walker F, Benifla JL, Meneux E, Guglielmina JM. Epithelial ovarian carcinoma of low malignant potential. Eur J Obstet Gynecol Reprod Biol 1996;66:141–145
   Google Scholar
• Buttini M, Nicklin JL, Crandon A. Low malignant potential ovarian tumours: a review of 175 consecutive cases. Aust NZ J Obstet Gynecol 1997;37: 100–103
   Google Scholar
• Barnhill DR, Kurman RJ, Brady MF, Omura GA, Yordan E, Given FT, et al. Preliminary analysis of the behavios of stage I ovarian serous tumors of low malignant potential: a Gynecologic Oncology Group study. J Clin Oncol 1995;13:2752–2756
   PubMedGoogle Scholar
• Gershenson DM, Silva EG, Tortolero-Luna G, Levenback C, Morris M, Tomos C. Serous borderline tumors of the ovary with noninvasive implants. Cancer 1998;83:2157–2163
   Google Scholar
• Goldstein NS, Ceniza N. Ovarian micropaillary serous borderline tumors: Clinicopathologic features and out-come of seven surgically staged patients. Am J Clin Pathol 2000;114:380–386
   Google Scholar
• Sherman ME, Mink PJ, Curtis R, Cote TR, Brooks S, Hartge P, et al. Survival among women with borderline ovarian tumors and ovarian carcinoma. Cancer 2004;100: 1045–1052
   PubMed Web of Science ®Google Scholar
• Trimble CL, Kosary C, Trimble EL. Long-term survival and patterns of care in women with ovarian tumors of low malignant potential. Gynecol Oncol 2002;86:34–37
   Google Scholar
• Bell DA, Scully RE. Ovarian serous borderline tumors with stromal microinvasion: a report of 21 cases. Hum Pathol 1990;21:397–403
   Google Scholar
• Lee KR, Scully RE. Mucinous tumors of the ovary: a clinicopathologic study of 196 borderline tumors (of intestinal type) and carcinomas, including an evaluation of 11 cases with `pseudomyxoma peritonei'. Am J Surg Path 2000;24:1447–1464
   PubMed Web of Science ®Google Scholar
• Ronnett BM, Kajdacsy-Ball A, Gilks CB, Merino MJ, Silva EG, Wemess BA, et al. Mucinous borderline ovarian tumors: Points of general agreement and persis-tent controversies regarding nomenclature, diagnostic criteria, and behavior. Hum Pathol 2004;35:949–960
   PubMed Web of Science ®Google Scholar
• Siriaunkgul S, Robbins KM, McGowan L, Silverberg SG. Ovarian mucinous tumors of low malignant potential: a clinicopathologic study of 54 tumors of intestinal and mullerian type. Int J Gynecol Pathol 1995;14:198–208
   Google Scholar
• Singer G, Oldt III R, Cohen Y, Wang BG, Sidransky D, Kurman RJ, et al. Mutations in BRAF and KRAS characterize the development of low-grade ovarian serous carcinoma. J Natl Cancer Inst 2003;95:484–486
   PubMed Web of Science ®Google Scholar
• Caduff RF, Svovoda-Newman SM, Ferguson AW, Johnston CM, Frank TS. Comparison of mutations of Ki-RAS and p53 immunoreactivity in borderline and malignant epithelial ovarian tumors. Am J Clin Pathol 1999;23:323–328
   Google Scholar
• Singer G, Stohr R, Cope L, Dehari R, Hartmann A, Cao D-F, et al. Patterns of p53 mutations separate ovarian serous borderline tumors and low- and high-grade carcinomas and provide support for a new model of ovarian carcinogenesis. Am J Surg Pathol 2005;29: 218–224
   Google Scholar
• Ortiz BH, Ailawadi M, Colitti C, Muto MG, Deavers M, Silva EG, et al. Second primary or recurrence? Compara-tive patterns of p53 and K-ras mutations suggest that serous borderline tumors and subsequent serous carcino-mas are unrelated tumors. Cancer Res 2001;61:7264–7267
   Google Scholar
• Gilks CB, Vanderhyden BC, Zhu S, van de Rijn M, Longacre TA. Distinction between serous tumors of low malignant potential and serous carcinomas based on global mRNA expression profiling. Gynecol Oncol 2005;96:684–694
   Google Scholar
• Ouellet V, Provencher DM, Maugard CM, Le Page C, Ren F, Lussier C, et al. Discrimination between serous low malignant potential and invasive epithelial ovarian tumors using molecular profiling. Oncogene 2005;24: 4672–4687
   Google Scholar
• Meinhold-Heerlein I, Bauerschlag D, Hilpert F, Dimitrov P, Sapinoso LM, Orlowska-Volk M, et al. Molecular and prognostic distinction between serous ovarian carcinomas of varying grade and malignant potential. Oncogene 2005;24:1053–1065
   Google Scholar
• Sui L, Dong Y, Ohno M, Sugimoto K, Tai Y, Hando T, et al. Implication of malignancy and prognosis of p27(kip 1), cyclin E, and cdk2 expression in epithelial ovarian tumors. Gynecol Oncol 2001;83:56–63
   PubMed Web of Science ®Google Scholar
• Warrenfeltz S, Pavlik S, Datta S, Kraemer ET, Benigno B, McDonald JF. Gene expression profiling of epithelial ovarian tumours correlated with malignant potential. Mol Cancer 2004;3:27
   PubMedGoogle Scholar
• Makarla PB, Saboorian MH, Ashfaq R, Toyooka KO, Toyooka S, Minna JD, et al. Promoter hypermethylation profile of ovarian epithelial neoplasms. Clin Cancer Res 2005;11:5365–5369
   PubMed Web of Science ®Google Scholar
• Camatte S, Morice P, Thoury A, Fourchotte V, Pautier P, Lhomme C, et al. Impact of surgical staging in patients with macroscopic "stage I" ovarian borderline tumours: analysis of a continuous series of 101 cases. Eur J Cancer 2004;40:1842–1849
   Google Scholar
• Lin PS, Gershenson DM, Bevers MW, Lucas KR, Burke TW, Silva EG. The current status of surgical staging of ovarian serous borderline tumors. Cancer 1999; 85:905–911
   PubMed Web of Science ®Google Scholar
• Camatte S, Morice P, Atallah D, Thoury A, Pautier P, Lhomme C, et al. Cinical outcome after laparo-scopic pure management of borderline ovarian tumors: results of a series of 34 patients. Ann Oncol 2004;15: 605–609
   Google Scholar
• Tozzi R, Kohler C, Ferrara A, Schneider A. Laparoscopic treatment of early ovarian cancer: surgical and survival outcomes. Gynecol Oncol 2004;93:199–203
   PubMed Web of Science ®Google Scholar
• Fauvet R, Boccara J, Dufoumet C, Poncelet C, Darai E. Laparoscopic management of borderline ovarian tumors: results of a French multicenter study. Ann Oncol 2005; 16:403–410
   Google Scholar
• Deffieux X, Morice P, Camatte S, Fourchotte V, Duvillard P, Castaigne D. Results after laparoscopic management of serous borderline tumor of the ovary with peritoneal implants. Gynecol Oncol 2005;97:84–89
   Google Scholar
• Barakat RR, Benjamin I, Lewis JL, Saigo PE, Curtin JP, Hoskins WJ. Platinum-based chemotherapy for advanced-stage serous ovarian carcinoma of low malignant poten-tial. Gynecol Oncol 1995;59:390–393
   PubMed Web of Science ®Google Scholar
• Houck K, Nikrui N, Duska L, Change Y, Fuller AF, Bell DA, et al. Borderline tumors of the ovary: Correla-tion of frozen and permanent histopathologic diagnosis. Obstet Gynecol 2000;95:839–843
   PubMed Web of Science ®Google Scholar
• Pinto PB, Andrade LA, Derchain SF. Accuracy of intraoperative frozen section diagnosis of ovarian tumors. Gynecol Oncol 2001;81:230–232
   Google Scholar
• Young RC, Decker DG, Wharton JT, Piver MS, Sindelar WF, Edwards BK, et al. Staging laparotomy in early ovarian cancer. JAMA 1983; 250:3072–3076
   PubMed Web of Science ®Google Scholar
• Land R, Perrin L, Nicklin JL. Evaluation of restaging in clinical stage IA low malignant potential ovarian tumours. Aust NZ J Obstet Gynecol 2002;42:379–382
   Google Scholar
• Leake JF, Rader JS, Woodruff JD, Rosenshein NB. Retroperitoneal lymphatic involvement with epithelial ovarian tumors of low malignant potential. Gynecol Oncol 1991;42:124–130
   PubMed Web of Science ®Google Scholar
• Snider DD, Stuart GC, Nation JG, Robertson DI. Evaluation of surgical staging in stage I low malignant potential ovarian tumors. Gynecol Oncol 1991;40:129–132
   PubMed Web of Science ®Google Scholar
• Beiner ME, Gotlieb WH, Davidson B, Kopolovic J, Ben-Baruch G. Infertility treatment after conservative man-agement of borderline ovarian tumors. Cancer 2001; 92:320–325
   Google Scholar
• Boran N, Tulunay G, Ozturkoglu E, Koc S, Bulbul D, Kose MF. Fertility and recurrence results of conservative surgery for borderline ovarian tumors. Gynecol Oncol 2005;97:845–851
   PubMed Web of Science ®Google Scholar
• Sutton GP, Bundy BN, Omura GA, Yordan EL, Beecham JB, Bonfiglio T. Stage III ovarian tumors of low malignant potential treated with cisplatin combination therapy (a Gynecologic Oncology Group study). Gynecol Oncol 1991;41:230–233
   PubMed Web of Science ®Google Scholar
• Casey AC, Bell DA, Lage JM, Fuller AF, Nikrui N, Rice L. Epithelial ovarian tumors of borderline malig-nancy: long-term follow-up. Gynecol Oncol 1993;50:316–322
   PubMed Web of Science ®Google Scholar
• Morris RT, Gershenson DM, Silva EG, Follen M, Morris M, Wharton JT. Outcome and reproductive function after conservative surgery for borderline ovarian tumors. Obstet Gynecol 2000;95:541–547
   PubMed Web of Science ®Google Scholar
• Rao GG, Skinner EN, Gehrig PA, Duska LR, Miller DM, Schorge JO. Fertility-sparing surgery for ovarian low malignant potential tumors. Gynecol Oncol 2005;98: 263–266
   PubMed Web of Science ®Google Scholar